Rice University engineers reported a charge-based strategy to improve controlled delivery of therapeutic peptides released from gelatin-based materials. By tuning how peptides are presented and released, the platform seeks to make small therapeutic peptides more practical for tissue engineering and drug delivery. The work matters for formulation teams because peptide stability and release kinetics often dictate whether candidate biologics reach effective exposure at target sites. The approach provides an additional control knob beyond typical material composition changes.